We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
G-CON Manufacturing and GE Healthcare Announce Intent to Collaborate in Developing Next Generation Modular Bio-therapeutic Manufacturing Technology
News

G-CON Manufacturing and GE Healthcare Announce Intent to Collaborate in Developing Next Generation Modular Bio-therapeutic Manufacturing Technology

G-CON Manufacturing and GE Healthcare Announce Intent to Collaborate in Developing Next Generation Modular Bio-therapeutic Manufacturing Technology
News

G-CON Manufacturing and GE Healthcare Announce Intent to Collaborate in Developing Next Generation Modular Bio-therapeutic Manufacturing Technology

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "G-CON Manufacturing and GE Healthcare Announce Intent to Collaborate in Developing Next Generation Modular Bio-therapeutic Manufacturing Technology"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

This collaboration combines GE Healthcare’s global presence and expertise in biopharmaceutical manufacturing technology with G-Con’s modular portable flexible clean-room technology. The collaboration will offer comprehensive GMP manufacturing solutions that are less expensive and quicker to build and maintain and easier to operate than any currently existing solution on the market.  

Together, the companies have the capability to design, build and deliver turnkey advanced bio-therapeutic manufacturing facilities throughout the world, and will be able to meet the growing market for rapid access to biopharmaceutical manufacturing capabilities, whether in developing markets, or for increased speed in situations such as pandemic response.

“GE Healthcare is a global life sciences leader, and we are excited by the market-changing next generation therapeutic manufacturing innovations this collaboration will be able to produce,” said Dr. Barry Holtz, President of G-Con Manufacturing, LLC.

“This collaboration is part of GE Healthcare’s mission to increase speed and access, and reduce cost for developers and manufacturers of bio-therapeutics and vaccines around the world,” said Nigel Darby, Vice President, Biotechnologies, GE Healthcare. “This collaboration means we move further towards our vision of modular and possibly mobile flexible bio-pharmaceutical manufacturing facilities – the vaccine factory in a box.”

Advertisement